ロード中...
Structure-based drug design of phenazopyridine derivatives as inhibitors of Rev1 interactions in translesion synthesis
Rev1 is a protein scaffold of the translesion synthesis (TLS) pathway, which employs low-fidelity DNA polymerases for replication of damaged DNA. The TLS pathway helps cancers tolerate DNA damage induced by genotoxic chemotherapy, and increases mutagenesis in tumors, accelerating the onset of chemor...
保存先:
| 出版年: | ChemMedChem |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035318/ https://ncbi.nlm.nih.gov/pubmed/33314657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.202000893 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|